相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutasynthesis of fluorosalinosporamide, a potent and reversible inhibitor of the proteasome
Alessandra S. Eustaquio et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Protein partners of deubiquitinating enzymes
Karen H. Ventii et al.
BIOCHEMICAL JOURNAL (2008)
Leucettamol A: A new inhibitor of Ubc13-Uev1A interaction isolated from a marine sponge, Leucetta aff. microrhaphis
Sachiko Tsukamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2
Mauricio Pineda-Roman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Argyrin A reveals a critical role for the tumor suppressor protein p27kip1 in mediating antitumor activities in response to proteasome inhibition
Irina Nickeleit et al.
CANCER CELL (2008)
The HECT family of E3 ubiquitin ligases: Multiple players in cancer development
Francesca Bernassola et al.
CANCER CELL (2008)
Proteasome inhibition by fellutamide B induces nerve growth factor synthesis
John Hines et al.
CHEMISTRY & BIOLOGY (2008)
Proteasome inhibitors in cancer therapy: Lessons from the first decade
Robert Z. Orlowski et al.
CLINICAL CANCER RESEARCH (2008)
Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer
Bruce D. Dorsey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Engineered biosynthesis of antiprotealide and other unnatural salinosporamide proteasome inhibitors
Ryan P. McGlinchey et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction
Patrick Schreiner et al.
NATURE (2008)
Proteasome subunit Rpn13 is a novel ubiquitin receptor
Koraljka Husnjak et al.
NATURE (2008)
A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism
Michael Groll et al.
NATURE (2008)
The genetics of the p53 pathway, apoptosis and cancer therapy
Alexei Vazquez et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction
Hwan-Ching Tai et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
Jesus F. San Miguel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Synthesis of 2,3- and 3,4-methanoamino acid equivalents with stereochemical diversity and their conversion into the tripeptide proteasome inhibitor belactosin A and its highly potent cis-cyclopropane stereoisomer
Keisuke Yoshida et al.
ORGANIC LETTERS (2008)
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
Roberto Piva et al.
BLOOD (2008)
A pivotal role for Mcl-1 in Bortezomib-induced apoptosis
K. Podar et al.
ONCOGENE (2008)
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myelorna
Deborah J. Kuhn et al.
BLOOD (2007)
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics
Yili Yang et al.
CANCER RESEARCH (2007)
NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells
Claudia P. Miller et al.
BLOOD (2007)
Identification of a peptoid inhibitor of the proteasome 19S regulatory particle
Hyun-Suk Lim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Regulation of CD8+ T cell development by thymus-specific proteasomes
Shigeo Murata et al.
SCIENCE (2007)
Proteasomes: Machines for all reasons
George N. DeMartino et al.
CELL (2007)
The proteasome: A worthwhile target for the treatment of solid tumours?
Amalia Milano et al.
EUROPEAN JOURNAL OF CANCER (2007)
Cinnabaramides A-G:: Analogues of lactacystin and salinosporamide from a terrestrial streptomycete
Marc Stadler et al.
JOURNAL OF NATURAL PRODUCTS (2007)
MDM2 inhibitors for cancer therapy
Lyubomir T. Vassilev
TRENDS IN MOLECULAR MEDICINE (2007)
Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities
Bernat Crosas et al.
CELL (2006)
Regulation of p53 localization and activity by Ubc13
Aaron Laine et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
A novel proteasome inhibitor NPI-0052 as an anticancer therapy
D. Chauhan et al.
BRITISH JOURNAL OF CANCER (2006)
The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia
Stacey Ruiz et al.
MOLECULAR CANCER THERAPEUTICS (2006)
TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome
Michael Groll et al.
CHEMISTRY & BIOLOGY (2006)
Crystal structures of salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of β-lactone ring opening and a mechanism for irreversible binding
M Groll et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Inhibitor-binding mode of homobelactosin C to proteasomes: New insights into class I MHC ligand generation
M Groll et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Success in translational research:: lessons from the development of bortezomib
I Sánchez-Serrano
NATURE REVIEWS DRUG DISCOVERY (2006)
An integrated mass spectrometry-based proteomic approach -: Quantitative analysis of tandem affinity-purified in vivo cross-linked protein complexes (QTAX) to decipher the 26 S proteasome-interacting network
C Guerrero et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Hexylitaconic acid: A new inhibitor of p53-HDM2 interaction isolated from a marine-derived fungus, Arthrinium sp.
S Tsukamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
D Chauhan et al.
CANCER CELL (2005)
7-Hydroxy-3-(4-hydroxybenzyl)chroman and broussonin B:: Neurotrophic compounds, isolated from Anemarrhena asphodeloides BUNGE, function as proteasome inhibitors
S Tsukamoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
New cytotoxic salinosporamides from the marine actinomycete Salinispora tropica
PG Williams et al.
JOURNAL OF ORGANIC CHEMISTRY (2005)
Proteasome-associated proteins: regulation of a proteolytic machine
M Schmidt et al.
BIOLOGICAL CHEMISTRY (2005)
Delivery of ubiquitinated substrates to protein-unfolding machines
S Elsasser et al.
NATURE CELL BIOLOGY (2005)
An efficient, stereocontrolled synthesis of a potent omuralide-salinosporin hybrid for selective proteasome inhibition
LR Reddy et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Structure-activity relationship studies of salinosporamide a (NPI-0052), a novel marine derived proteasome inhibitor
VR Macherla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Secomycalolide A:: A new proteasome inhibitor isolated from a marine sponge of the genus Mycale
Sachiko Tsukamoto et al.
MARINE DRUGS (2005)
Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib
CR Berkers et al.
NATURE METHODS (2005)
Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome
I Momose et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-Cell non-Hodgkin's lymphoma
A Goy et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting
H Richly et al.
CELL (2005)
Himeic acid A:: a new ubiquitin-activating enzyme inhibitor isolated from a marine-derived fungus, Aspergillus sp.
S Tsukamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Function and regulation of Cullin-RING ubiquitin ligases
MD Petroski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
The proteasome: A suitable antineoplastic target
J Adams
NATURE REVIEWS CANCER (2004)
Intracellularly inducible, ubiquitin hydrolase-insensitive tandem ubiquitins inhibit the 26S proteasome activity and cell division
Y Saeki et al.
GENES & GENETIC SYSTEMS (2004)
TMC-95A, a reversible proteasome inhibitor, induces neurite outgrowth in PC12 cells
M Inoue et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
A new structural class of proteasome inhibitors identified by microbial screening using yeast-based assay
A Asai et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system
R Verma et al.
CELL (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
Approval summary for bortezomib for injection in the treatment of multiple myeloma
PF Bross et al.
CLINICAL CANCER RESEARCH (2004)
Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain
R Verma et al.
SCIENCE (2004)
Girolline, an antitumor compound isolated from a sponge, induces G2/M cell cycle arrest and accumulation of polyubiquitinated p53
S Tsukamoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Functional analysis of genes involved in the synthesis of syringolin A by Pseudomonas syringae pv. syringae B301D-R
H Amrein et al.
MOLECULAR PLANT-MICROBE INTERACTIONS (2004)
Involvement of the DNA repair protein hHR23 in p53 degradation
S Glockzin et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
New polyhydroxy sterols:: Proteasome inhibitors from a marine sponge Acanthodendrilla sp.
S Tsukamoto et al.
JOURNAL OF NATURAL PRODUCTS (2003)
Potential for proteasome inhibition in the treatment of cancer
J Adams
DRUG DISCOVERY TODAY (2003)
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
N Mitsiades et al.
BLOOD (2003)
Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora
RH Feling et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome
R Verma et al.
SCIENCE (2002)
Panepophenanthrin, from a mushroom strain, a novel inhibitor of the ubiquitin-activating enzyme
R Sekizawa et al.
JOURNAL OF NATURAL PRODUCTS (2002)
Argyrins, immunosuppressive cyclic peptides from myxobacteria - I. Production, isolation, physico-chemical and biological properties
F Sasse et al.
JOURNAL OF ANTIBIOTICS (2002)
Cdc48-Ufd1-NpI4: Stuck in the middle with Ub
NW Bays et al.
CURRENT BIOLOGY (2002)
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
MH Glickman et al.
PHYSIOLOGICAL REVIEWS (2002)
Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp MK993-dF2 -: II.: Structure determination and synthesis
I Momose et al.
JOURNAL OF ANTIBIOTICS (2001)
Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp MK993-dF2 -: I.: Taxonomy, isolation, physico-chemical properties and biological activities
S Momose et al.
JOURNAL OF ANTIBIOTICS (2001)
Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling
J Demand et al.
CURRENT BIOLOGY (2001)
Crystal structure of the 20 S proteasome: TMC-95A complex: A non-covalent proteasome inhibitor
M Groll et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Antigen processing by the proteasome
PM Kloetzel
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Isolation and structure elucidation of chlorofusin, a novel p53-MDM2 antagonist from a Fusarium sp.
SJ Duncan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Proteasomal proteomics: Identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes
R Verma et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Apoptosis and radiosensitization of Hodgkin cells by proteasome inhibition
F Pajonk et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Structures of TMC-95A-D:: Novel proteasome inhibitors from Apiospora montagnei Sacc. TC 1093
J Kohno et al.
JOURNAL OF ORGANIC CHEMISTRY (2000)
The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome
J Lüders et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093 -: Taxonomy, production, isolation, and biological activities
Y Koguchi et al.
JOURNAL OF ANTIBIOTICS (2000)
分享论文
